What caused the pre-market drop in OBSN.SW stock today?

The pre-market drop to CHF0.001 was driven by outsized selling and a volume surge to 2,351,202 shares. No immediate public earnings or clinical release explains the move, suggesting liquidity events or trading flows in the microcap stock

What is Meyka AI's forecast for OBSN.SW stock?

Meyka AI's forecast model projects a 12-month base-case of CHF0.010 for OBSN.SW stock, implying about 900.00% upside from CHF0.001. Forecasts are model-based projections and not guarantees

Is OBSN.SW a buy, hold, or sell based on current data?

Meyka AI assigns OBSN.SW a **B** grade with a HOLD suggestion. The rating balances sector context, financial metrics and market activity but is informational only and not investment advice

What are the main risks for OBSN.SW stock investors?

Primary risks include further share dilution, negative operating cash flow, clinical trial setbacks, and very low liquidity that can magnify price moves. Active risk management is essential for traders in OBSN.SW

CH Stocks

OBSN.SW ObsEva S.A. pre-market SIX 20 Feb 2026: -76.92% to CHF0.001, high volume

ByHuzaifa Zahoor February 20, 2026

OBSN.SW stock opened pre-market on the SIX exchange on 20 Feb 2026 at CHF0.001, down 76.92% from the previous close as volume surged to 2,351,202 shares. That price sits at the year low of CHF0.001 and well below the 50-day average of CHF0.015 and 200-day average of CHF0.044. Traders label ObsEva S.A. (OBSN.SW) among the most active Swiss small-caps this session, driven by heavy selling and speculative buying. We examine the drivers, financial metrics, and short-term scenarios for the stock on SIX in Switzerland.